NOVEL RAC PATHWAY INHIBITORS FOR THE TREATMENT OF METASTATIC RAS/MAPK ACTIVATED LEUKEMIA

$1,564,751FY2025Defense Health AgencyDOD

Childrens Hospital Medical Center

Investigators